Big government institutionalized medical science is taking a big step in the direction of integrative oncology. They are actually doing something that acknowledges the body’s natural immune system in fighting cancer. The National Cancer Institute (NCI) is conducting a Phase I clinical trial of an agent (not a drug) that enhances the immune system as the primary opponent of metastatic malignant melanoma and metastatic renal cell cancer, a kidney cancer.

“For an oncologist, communication with patients is the cornerstone of patient care and management…Poor communication can result in less effective anticancer treatment or increased toxicity—and even shorter survival.” This statement is from an article in yesterday’s Journal of Oncology by Nathan Cherny. It highlights a historical concern within the field of conventional oncology and a principal value of integrative oncologists. Cherny’s article is an indictment of the doctor-patient relationship in typical cancer treatment. During my former wife’s three-year chemotherapy ordeal, I cannot recall one single session where our doctor discussed seriously the treatment protocol, how it would affect us, and our own feelings about it.